Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 21.95% | 75.36 | 6.5% | $147.38m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.98% | 19.37 | 14.1% | $113.98m | |
| CTLT | Catalent, Inc. | 1.67% | 89.66 | 2.1% | $94.55m | |
| BHC | Bausch Health Cos., Inc. | 1.99% | 19.37 | 0.0% | $64.85m | |
| JAZZ | Jazz Pharmaceuticals Plc | 10.36% | 121.93 | 2.4% | $64.61m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | 5.79% | 1.28 | 3.9% | $63.68m | |
| ARGX | argenx SE | 0.77% | 233.39 | 0.0% | $46.97m | |
| PCRX | Pacira Biosciences, Inc. | 1.72% | 56.23 | 10.3% | $44.65m | |
| ICLR | ICON plc | 1.71% | 190.28 | 4.3% | $42.55m | |
| UTHR | United Therapeutics Corp. | -0.68% | 113.31 | 14.1% | $42.19m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 0.04% | 47.60 | 16.8% | $41.47m | |
| PRGO | Perrigo Co. Plc | -5.06% | 52.33 | 6.8% | $40.16m | |
| GWPH | GW Pharmaceuticals Plc | -0.44% | 134.77 | 6.2% | $37.99m | |
| MYOK | MyoKardia, Inc. | 1.35% | 99.32 | 1.8% | $36.53m | |
| AMRN | Amarin Corp. Plc | -3.91% | 6.76 | 1.5% | $35.89m |
Company Profile
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.